Low-dose Cortisol in Chronic Posttraumatic Stress Disorder
Posttraumatic Stress Disorder
About this trial
This is an interventional treatment trial for Posttraumatic Stress Disorder focused on measuring PTSD, cortisol, memory, treatment
Eligibility Criteria
Inclusion Criteria: Female and male patients with chronic PTSD due to adult trauma; PTSD is diagnosed according to the DSM-IV, as measured with the CAPS Age between 18 and 60 Exclusion Criteria: History of disease states representing contraindications to glucocorticoid therapy (tuberculosis, gastritis, gastric- and duodenal ulcers, Cushing's disease, osteoporosis, hypertension, pregnancy (to exclude with a pregnancy test) and lactation, glaucoma, diabetes mellitus, thrombophilia, acute or chronic infections, hyperthyroidism, cirrhosis) Severe or chronic somatic diseases Topic glucocorticoid therapy (for large skin parts) Inhaled glucocorticoids Current psychotic, bipolar, substance-related, or severe personality disorder Current severe depressive disorder Severe cognitive impairment or a history of organic mental disorder Evidence of PTSD or depression immediately prior to the index trauma Prominent current suicidal or homicidal ideation Asylum seeking status Body weight >20% above or below normal range Changes in psychopharmacologic or psychotherapeutic management less than 8 weeks before start of the study
Sites / Locations
- Department of Psychiatry, University Hospital Zurich